Open AccessRepeated loco-regional therapies for hepatocellular carcinoma is associated with inferior outcome after living donor liver transplantation in cirrhotic patients
Author(s) -
Yi-Fan Tsou,
NiangCheng Lin,
ChengYuan Hsia,
CheChuan Loong,
HungPei Tsai,
ChengYen Chen,
HaoJan Lei,
ShuCheng Chou,
Ming-Hua Chung,
Fang-Cheng Kuo,
Chinsu Liu
Publication year - 2022
Publication title -
journal of the chinese medical association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.535
H-Index - 42
eISSN - 1728-7731
pISSN - 1726-4901
DOI - 10.1097/jcma.0000000000000670
Subject(s) - medicine , hepatocellular carcinoma , liver transplantation , cirrhosis , gastroenterology , milan criteria , proportional hazards model , multivariate analysis , univariate analysis , liver disease , transplantation , model for end stage liver disease , liver cancer , oncology
Liver transplantation is the definitive treatment for defined stage hepatocellular carcinoma (HCC) in cirrhotic patients. Loco-regional therapy (LRT) may be considered before transplantation to prevent the disease progression and the patient from dropping out of the waiting list. This study aims to evaluate the impact of repeated pretransplant LRTs on the long-term outcomes in HCC liver transplant recipients.